VAV1 and cancer: The sequencing of human cancers of multiple tissue origins by the Human Genome Sequencing program (Wellcome Trust Sanger Institute) demonstrates that VAV1 is mutated in ~1% of the tumors (http://cancer.sanger.ac.uk).